pharmaceuticals

Federal Court of Appeal affirms trademark confusion between names of eye medicines

By Pardeep Heir, Paul Jorgensen & Kristin Wall on December 22, 2025

The Federal Court of Appeal (FCA) has affirmed a Federal Court (FC) decision finding that the brand name of a biosimilar drug (BYOOVIZ) was confusingly similar with the brand name of a biologic drug (BEOVU), even…

Canada announces its first-ever national strategy for drugs for rare diseases

By Sarah Pennington, Paul Jorgensen & Kristin Wall on March 27, 2023

On March 22, 2023, Canada’s federal government announced its first-ever National Strategy for Drugs for Rare Diseases, including an investment of up to $1.5 billion over three years to help increase drug access and affordability.

Investments made as part

…

Pharma in Brief

pharmaceuticals

Federal Court of Appeal affirms trademark confusion between names of eye medicines

Canada announces its first-ever national strategy for drugs for rare diseases

Investments made as part

About

Topics

Archives